Cartesian Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | — | — | $8.1M |
| FY2014 | — | — | $16.6M |
| FY2015 | $21.8M | $42.8M | $32.3M |
| FY2016 | $34.3M | $89.3M | $58.7M |
| FY2017 | $49.3M | $101.1M | $70.6M |
| FY2018 | $47.5M | $101.1M | $37.4M |
| FY2019 | $91.2M | $99.6M | $89.9M |
| FY2020 | $183.4M | $165.4M | $138.7M |
| FY2021 | $137.4M | $159.9M | $114.1M |
| FY2022 | $72.1M | $165.9M | $106.4M |